"RIV/00064173:_____/08:#0000015" . "10" . "Positron emission tomography has a high negative predictive value (NPV) for progression or early relapse for patients with residual disease after first-line chemoterapy in advanced-stage Hodgkin lymphoma."@en . "emission tomography; progression or early relapse; Hodgkin lymphoma"@en . "V multicentrick\u00E9 randomizovan\u00E9 prospektivn\u00ED studii HD15 German Hodgkin Study Group (GHSG) pro pokro\u010Dil\u00E1 st\u00E1dia Hodgkinova lymfomu byla hodnocena negativn\u00ED prediktivn\u00ED hodnota (NPV) pozitronov\u00E9 emisn\u00ED tomografie (PET) s /(18)F/- fluorodeoxygluk\u00F3zou. 871 pacient\u016F bylo l\u00E9\u010Deno chemoterapi\u00ED BEACOPP. Pomoc\u00ED PET byl u 311 pacient\u016F po ukon\u010Den\u00E9 chemoterapii hodnocen rezidu\u00E1ln\u00ED tumor ->2,5 cm. NPV PET byla definovan\u00E1 jako pom\u011Br PET (-) negativn\u00EDch pacient\u016F bez progrese, relapsu nebo radioterapie po dobu 12 m\u011Bs\u00EDc\u016F po hodnocen\u00ED centr\u00E1ln\u00EDm PET panelem ( v Kol\u00EDn\u011B nad R\u00FDnem)." . "In the HD15 trial of the German Hodgkin Study Group, the negative predictive value ( NPV) of positron emission tomography ( PET) using [ (18)F]- fluorodeoxyglucose in advanced-stage Hodgkin lymphoma ( HL) was evaluated. A total of 817 patients were enrolled and randomly assigned to receive BEACOPP- based chemotherapy. After completion of chemotherapy, residual disease measuring more than or equal to 2,5 cm in diameter was assessed by PET in 311 patients. The NPV of PET was defined as the proportion of PET (-) patients without progression, relapse, or irradiation within 12 months after PET review panel. This trial is registered at http://isrctn.org study as # ISRCTN32443041."@en . . . "6"^^ . "V multicentrick\u00E9 randomizovan\u00E9 prospektivn\u00ED studii HD15 German Hodgkin Study Group (GHSG) pro pokro\u010Dil\u00E1 st\u00E1dia Hodgkinova lymfomu byla hodnocena negativn\u00ED prediktivn\u00ED hodnota (NPV) pozitronov\u00E9 emisn\u00ED tomografie (PET) s /(18)F/- fluorodeoxygluk\u00F3zou. 871 pacient\u016F bylo l\u00E9\u010Deno chemoterapi\u00ED BEACOPP. Pomoc\u00ED PET byl u 311 pacient\u016F po ukon\u010Den\u00E9 chemoterapii hodnocen rezidu\u00E1ln\u00ED tumor ->2,5 cm. NPV PET byla definovan\u00E1 jako pom\u011Br PET (-) negativn\u00EDch pacient\u016F bez progrese, relapsu nebo radioterapie po dobu 12 m\u011Bs\u00EDc\u016F po hodnocen\u00ED centr\u00E1ln\u00EDm PET panelem ( v Kol\u00EDn\u011B nad R\u00FDnem)."@cs . "21"^^ . . . "Blood" . . "Markov\u00E1, Jana" . "P(NR8033)" . . "[93B2277666DB]" . "Vysok\u00E1 negativn\u00ED prediktivn\u00ED hodnota (NPV) pozitronov\u00E9 emisn\u00ED tomografie pro progresi nebo \u010Dasn\u00FD relaps u pacient\u016F s rezidu\u00E1ln\u00EDm tumorem po prvn\u00ED linii l\u00E9\u010Dby pokro\u010Dil\u00E9ho Hodgkinova lymphoma."@cs . . . "0006-4971" . . "Vysok\u00E1 negativn\u00ED prediktivn\u00ED hodnota (NPV) pozitronov\u00E9 emisn\u00ED tomografie pro progresi nebo \u010Dasn\u00FD relaps u pacient\u016F s rezidu\u00E1ln\u00EDm tumorem po prvn\u00ED linii l\u00E9\u010Dby pokro\u010Dil\u00E9ho Hodgkinova lymphoma." . "RIV/00064173:_____/08:#0000015!RIV09-MZ0-00064173" . . "Vysok\u00E1 negativn\u00ED prediktivn\u00ED hodnota (NPV) pozitronov\u00E9 emisn\u00ED tomografie pro progresi nebo \u010Dasn\u00FD relaps u pacient\u016F s rezidu\u00E1ln\u00EDm tumorem po prvn\u00ED linii l\u00E9\u010Dby pokro\u010Dil\u00E9ho Hodgkinova lymphoma." . . . . "Vysok\u00E1 negativn\u00ED prediktivn\u00ED hodnota (NPV) pozitronov\u00E9 emisn\u00ED tomografie pro progresi nebo \u010Dasn\u00FD relaps u pacient\u016F s rezidu\u00E1ln\u00EDm tumorem po prvn\u00ED linii l\u00E9\u010Dby pokro\u010Dil\u00E9ho Hodgkinova lymphoma."@cs . "Positron emission tomography has a high negative predictive value (NPV) for progression or early relapse for patients with residual disease after first-line chemoterapy in advanced-stage Hodgkin lymphoma."@en . "404400" . "1"^^ . "112" . . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . .